Role of acetylcholinesterase inhibitors in the regulation of amyloid β precursor protein (AβPP) metabolism
- 1 December 2005
- journal article
- research article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 157-158, 335-338
- https://doi.org/10.1016/j.cbi.2005.10.099
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Acetylcholinesterase inhibitors: novel activities of old moleculesPharmacological Research, 2004
- Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell linesJournal of Neurochemistry, 2004
- Characterization of the effect of ganstigmine (CHF2819) on amyloid precursor protein metabolism in SH-SY5Y neuroblastoma cellsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2003
- The pharmacology of amyloid precursor protein processingExperimental Gerontology, 2003
- Long-term stabilizing effect of cholinesterase inhibitors in the therapy of Alzheimer’ diseasePublished by Springer Nature ,2002
- Short- and long-term effect of acetylcholinesterase inhibition on the expression and metabolism of the amyloid precursor proteinMolecular Psychiatry, 2001
- In vitro effects of metrifonate on neuronal amyloid precursor protein processing and protein kinase C levelBrain Research, 2000
- Effects of Cholinesterase Inhibitors on the Secretion of Beta‐Amyloid Precursor Protein in Cell CulturesaAnnals of the New York Academy of Sciences, 1997
- The cholinergic system in Alzheimer's diseaseProgress in Neurobiology, 1997
- Release of Alzheimer Amyloid Precursor Derivatives Stimulated by Activation of Muscarinic Acetylcholine ReceptorsScience, 1992